CRITICAL-EVALUATION OF THE EFFECTS OF CHRONIC OCULAR TREATMENT WITH THE DIPEPTIDE N-ACETYL-ASPARTYL-GLUTAMIC ACID (MG-NAAGA) - SEROLOGICAL,HISTOLOGICAL AND ULTRASTRUCTURAL OBSERVATIONS
S. Sanfilippo et al., CRITICAL-EVALUATION OF THE EFFECTS OF CHRONIC OCULAR TREATMENT WITH THE DIPEPTIDE N-ACETYL-ASPARTYL-GLUTAMIC ACID (MG-NAAGA) - SEROLOGICAL,HISTOLOGICAL AND ULTRASTRUCTURAL OBSERVATIONS, Biogenic amines, 12(3), 1996, pp. 225-232
Ocular and systemic subacute Mg-Naaga tolerability was evaluated in be
agle dogs, treated at the same time by intraconjunctival application (
0.05 ml q.i.d. of a 6% collyrium preparation), and by oral route (150-
300 or 600 mg/kg/die of the pure substance in a single dose). Before t
he beginning of the treatment and every 30 days thereafter blood sampl
es were drawn in order to perform routine laboratory analyses. At the
end of the study 4 animals per group were sacrificed both eyes with op
tic nerves and principal splanchnic organs removed, and then examined
by light and electron microscopy. Hematochemical and histological inve
stigations clearly demonstrated the absolute absence of toxicity of th
e drug. The ultrastructural investigation confirmed the lack of toxici
ty, and demonstrated the activation of tissutal clearance mechanisms e
licited by the drug at ocular level.